Company Confirms FY26 Revenue Outlook of $128M to $132M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 07 2026
0mins
Should l Buy CCLD?
Backs FY26 revenue view $128M-$132M, consensus $131.23M. Backs FY26 adjusted EBITDA $29M-$31M. The company said, "Revenue guidance is based on management's expectations for contributions from existing clients, together with cross-selling and other organic and inorganic growth. EPS guidance of $0.20-$0.23 represents a 100-130% increase from the $0.10 achieved in full year 2025. Adjusted EBITDA guidance is $29-$31 million compared to the 2025 amount of $27.5 million."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CCLD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CCLD
Wall Street analysts forecast CCLD stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.120
Low
3.25
Averages
6.42
High
8.00
Current: 2.120
Low
3.25
Averages
6.42
High
8.00
About CCLD
CareCloud, Inc. is a provider of technology-enabled services and generative artificial intelligence (AI) solutions that redefine the healthcare revenue cycle management process. It provides technology-enabled revenue cycle management and a full suite of proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its Healthcare IT segment includes technology-assisted revenue cycle management, software-as-a-service solutions and professional and other services. Its Medical Practice Management segment includes the management of three medical practices. Its technology-enabled business solutions include Technology-enabled revenue cycle management, Cloud-based software, Digital health, and Healthcare IT professional services & staffing. Its revenue cycle management services, including end-to-end medical billing, eligibility, analytics, and related services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CareCloud Q1 2026 Earnings Call Highlights
- Significant Revenue Growth: CareCloud reported Q1 2026 revenue of $31.3 million, reflecting a 13% year-over-year increase, indicating accelerated commercial traction in its AI platform and enhanced market competitiveness.
- Capital Structure Simplification: The company closed a new $50 million credit facility on April 13 and plans to redeem 100% of its Series B preferred stock on May 15, which is expected to reduce the burden of high-cost preferred dividends and improve financial health.
- Strong AI Platform Performance: Since its full commercial release in December, the StratusAI Desk Agent is now handling approximately 75% of inbound calls automatically, showcasing its broad applicability in the healthcare sector, with an addressable market exceeding $4 billion.
- 2026 Guidance Reaffirmed: Management reaffirmed the 2026 revenue target of $128 million to $132 million and adjusted EBITDA of $29 million to $31 million, demonstrating confidence in continued growth driven by RCM business and AI revenue contributions.
See More
CareCloud Q1 Earnings Beat Expectations with Revenue Growth
- Revenue Growth: CareCloud reported Q1 revenue of $31.3 million, reflecting a 13.4% year-over-year increase, which exceeded market expectations by $0.79 million, indicating the company's sustained growth potential in the healthcare sector.
- Non-GAAP EPS: The company posted a non-GAAP EPS of $0.05, in line with expectations, demonstrating stable profitability, although GAAP EPS was reported at -$0.01, showing improvement compared to the previous year's figure.
- Adjusted EBITDA: Adjusted EBITDA stood at $5.4 million, slightly down from $5.6 million in the prior year, indicating some pressure on cost control while still maintaining positive cash flow.
- Net Income Change: GAAP net income was $922,000, down from $1.9 million year-over-year, highlighting challenges in profitability that necessitate attention to future financial strategies to enhance performance.
See More
CareCloud Scheduled to Announce Q1 Earnings on May 7
- Earnings Announcement Schedule: CareCloud (CCLD) is set to announce its Q1 earnings on May 7 before market open, with consensus EPS estimate at $0.05, flat year-over-year, and revenue expected at $30.51 million, reflecting a 10.5% year-over-year increase.
- Performance Expectation Analysis: Over the past two years, CCLD has beaten EPS estimates 50% of the time and revenue estimates 75% of the time, indicating a degree of stability in financial performance and market confidence.
- Estimate Revision Dynamics: In the last three months, there has been one upward revision in EPS estimates with no downward adjustments, suggesting analysts' optimistic outlook on the company's future performance, which could positively impact stock prices.
- Financing Background: CareCloud recently secured a $50 million credit facility and redeemed preferred stock, a move that not only enhances the company's financial flexibility but may also provide funding support for future growth.
See More
CareCloud Secures $50M Credit Facility to Support Growth
- Credit Facility Secured: CareCloud announced a $50 million credit facility agreement with Citizens Bank and Provident Bank, which will provide essential funding to support the company's operations and growth initiatives, enhancing its competitive edge in the healthcare technology sector.
- Preferred Stock Redemption: The company plans to fully redeem all outstanding Series B preferred shares on May 15, which is expected to eliminate approximately $3.2 million in annual dividend obligations, thereby simplifying its capital structure and reducing financing costs.
- Liquidity Improvement: Through this credit facility and the redemption of preferred shares, CareCloud aims to improve liquidity and enhance financial flexibility to better support the expansion of its AI-driven healthcare technology platform.
- Market Reaction: Following the announcement, CareCloud's stock price rose 1.42% in pre-market trading to $2.76, reflecting a positive market response to the company's strategic initiatives.
See More
CareCloud Secures $50 Million Credit Facility to Enhance Financial Flexibility
- Successful Financing: CareCloud announced the closing of a $50 million credit facility with Citizens Bank and Provident Bank on April 13, 2026, marking a significant advancement in optimizing its capital structure and enhancing liquidity and financial flexibility.
- Preferred Stock Redemption: The company plans to redeem all 1,511,372 shares of its 8.75% Series B Cumulative Redeemable Preferred Stock on May 15, 2026, at a total redemption price of $27.52 per share, which is expected to eliminate approximately $3.2 million in annual preferred dividend obligations and simplify its capital structure.
- EBITDA Performance: CareCloud currently generates approximately $30 million in annualized adjusted EBITDA, underscoring the strength of its operating model and supporting the transition to lower-cost institutional financing, thereby improving financial flexibility.
- Strategic Development: This financing aligns with the company's strategy to expand its AI-driven platform, aiming to enhance operational efficiency and scalability, drive organic growth across its core revenue cycle management platform, and ultimately increase long-term shareholder value.
See More
CARECLOUD INC - CYBERSECURITY ISSUE ADDRESSED; OPERATIONS UNHARMED
- Incident Overview: A cybersecurity incident occurred at CareCloud Inc.
- Impact Assessment: The incident did not have any material impact on operations.
See More
CareCloud Q1 2026 Earnings Call Highlights
- Significant Revenue Growth: CareCloud reported Q1 2026 revenue of $31.3 million, reflecting a 13% year-over-year increase, indicating accelerated commercial traction in its AI platform and enhanced market competitiveness.
- Capital Structure Simplification: The company closed a new $50 million credit facility on April 13 and plans to redeem 100% of its Series B preferred stock on May 15, which is expected to reduce the burden of high-cost preferred dividends and improve financial health.
- Strong AI Platform Performance: Since its full commercial release in December, the StratusAI Desk Agent is now handling approximately 75% of inbound calls automatically, showcasing its broad applicability in the healthcare sector, with an addressable market exceeding $4 billion.
- 2026 Guidance Reaffirmed: Management reaffirmed the 2026 revenue target of $128 million to $132 million and adjusted EBITDA of $29 million to $31 million, demonstrating confidence in continued growth driven by RCM business and AI revenue contributions.
See More
CareCloud Q1 Earnings Beat Expectations with Revenue Growth
- Revenue Growth: CareCloud reported Q1 revenue of $31.3 million, reflecting a 13.4% year-over-year increase, which exceeded market expectations by $0.79 million, indicating the company's sustained growth potential in the healthcare sector.
- Non-GAAP EPS: The company posted a non-GAAP EPS of $0.05, in line with expectations, demonstrating stable profitability, although GAAP EPS was reported at -$0.01, showing improvement compared to the previous year's figure.
- Adjusted EBITDA: Adjusted EBITDA stood at $5.4 million, slightly down from $5.6 million in the prior year, indicating some pressure on cost control while still maintaining positive cash flow.
- Net Income Change: GAAP net income was $922,000, down from $1.9 million year-over-year, highlighting challenges in profitability that necessitate attention to future financial strategies to enhance performance.
See More
CareCloud Scheduled to Announce Q1 Earnings on May 7
- Earnings Announcement Schedule: CareCloud (CCLD) is set to announce its Q1 earnings on May 7 before market open, with consensus EPS estimate at $0.05, flat year-over-year, and revenue expected at $30.51 million, reflecting a 10.5% year-over-year increase.
- Performance Expectation Analysis: Over the past two years, CCLD has beaten EPS estimates 50% of the time and revenue estimates 75% of the time, indicating a degree of stability in financial performance and market confidence.
- Estimate Revision Dynamics: In the last three months, there has been one upward revision in EPS estimates with no downward adjustments, suggesting analysts' optimistic outlook on the company's future performance, which could positively impact stock prices.
- Financing Background: CareCloud recently secured a $50 million credit facility and redeemed preferred stock, a move that not only enhances the company's financial flexibility but may also provide funding support for future growth.
See More
CareCloud Secures $50M Credit Facility to Support Growth
- Credit Facility Secured: CareCloud announced a $50 million credit facility agreement with Citizens Bank and Provident Bank, which will provide essential funding to support the company's operations and growth initiatives, enhancing its competitive edge in the healthcare technology sector.
- Preferred Stock Redemption: The company plans to fully redeem all outstanding Series B preferred shares on May 15, which is expected to eliminate approximately $3.2 million in annual dividend obligations, thereby simplifying its capital structure and reducing financing costs.
- Liquidity Improvement: Through this credit facility and the redemption of preferred shares, CareCloud aims to improve liquidity and enhance financial flexibility to better support the expansion of its AI-driven healthcare technology platform.
- Market Reaction: Following the announcement, CareCloud's stock price rose 1.42% in pre-market trading to $2.76, reflecting a positive market response to the company's strategic initiatives.
See More
CareCloud Secures $50 Million Credit Facility to Enhance Financial Flexibility
- Successful Financing: CareCloud announced the closing of a $50 million credit facility with Citizens Bank and Provident Bank on April 13, 2026, marking a significant advancement in optimizing its capital structure and enhancing liquidity and financial flexibility.
- Preferred Stock Redemption: The company plans to redeem all 1,511,372 shares of its 8.75% Series B Cumulative Redeemable Preferred Stock on May 15, 2026, at a total redemption price of $27.52 per share, which is expected to eliminate approximately $3.2 million in annual preferred dividend obligations and simplify its capital structure.
- EBITDA Performance: CareCloud currently generates approximately $30 million in annualized adjusted EBITDA, underscoring the strength of its operating model and supporting the transition to lower-cost institutional financing, thereby improving financial flexibility.
- Strategic Development: This financing aligns with the company's strategy to expand its AI-driven platform, aiming to enhance operational efficiency and scalability, drive organic growth across its core revenue cycle management platform, and ultimately increase long-term shareholder value.
See More
CARECLOUD INC - CYBERSECURITY ISSUE ADDRESSED; OPERATIONS UNHARMED
- Incident Overview: A cybersecurity incident occurred at CareCloud Inc.
- Impact Assessment: The incident did not have any material impact on operations.
See More
